Results 121 to 130 of about 5,308 (216)

Functional and Morphological Responses to Fluocinolone Acetonide 0.19 mg in Noninfectious Uveitic Macular Edema Evaluated as the Area-Under-the-Curve. [PDF]

J Ocul Pharmacol Ther, 2023
Kessler LJ, Auffarth GU, Khoramnia R.
europepmc   +1 more source

Radiation-induced maculopathy and fluocinolone acetonide implant. [PDF]

Graefes Arch Clin Exp Ophthalmol
Fricker J, Nahon-Esteve S, Tick S, Nhari M, Chotard G, Nguyen AM, Baillif S, Kodjikian L, Mathis T.   +8 more
europepmc   +1 more source

Prevalence and Risk Factors of Ocular Hypertension Following Fluocinolone Acetonide (Iluvien^®) Intravitreal Injections: The "SAFAC" Study. [PDF]

Ophthalmol Ther
Serrar Y, Sejournet L, Allignet B, Bounetta S, Deiri M, Gullon C, Malclès A, Denis P, Mathis T, Kodjikian L.   +9 more
europepmc   +1 more source

Intravitreal fluocinolone acetonide 0.19 mg (ILUVIEN®) in patients with non-infectious uveitis: real-world effectiveness and safety outcomes at 12 months. [PDF]

Int Ophthalmol, 2023
Moll-Udina A, Hernanz I, Sainz-de-la-Maza M, Pelegrín L, Coelho-Borges AI, Pazos M, Adán A, Llorenç V.   +7 more
europepmc   +1 more source

Near-complete clinical improvement of an extensive congenital acantholytic epidermal nevus treated with topical fluocinolone acetonide/hydroquinone/tretinoin (Tri-luma): A case report. [PDF]

JAAD Case Rep
Rivera Ocampo S.
europepmc   +1 more source

Characterization of Transcriptomic and Proteomic Changes in the Skin after Chronic Fluocinolone Acetonide Treatment. [PDF]

Biomolecules, 2022
Choi Y, Takasugi M, Takemura K, Yoshida Y, Kamiya T, Adachi J, Tsuruta D, Ohtani N.   +7 more
europepmc   +1 more source

Clinical effectiveness of the 0.18 mg fluocinolone acetonide intravitreal implant for non-infectious uveitis-associated macular edema: a real-world study. [PDF]

BMC Ophthalmol
Chen C, Zhang WJ, Ding Q, Shen SM, Ye Y, Huang Z, Yan M, Song YP.   +7 more
europepmc   +1 more source

Fluocinolone Acetonide Enhances Anterograde Mitochondria Trafficking and Promotes Neuroprotection against Paclitaxel-Induced Peripheral Neuropathy. [PDF]

ACS Chem Neurosci, 2023
Tiwari AP, Tristan LJC, Albin B, Yang IH.   +3 more
europepmc   +1 more source

Long-term outcomes of intravitreal 0.19 mg fluocinolone acetonide implant in uveitic macular edema after prior local corticosteroid treatments. [PDF]

J Ophthalmic Inflamm Infect
Ferreira AM, Silva MI, Torres-Costa S, Oliveira-Ferreira C, Pedrosa AC, Figueira L, Araújo JR.   +6 more
europepmc   +1 more source

CHOROIDAL LESIONS UNRESPONSIVE TO FLUOCINOLONE ACETONIDE INTRAVITREAL IMPLANT IN BIRDSHOT CHORIORETINOPATHY. [PDF]

Retin Cases Brief Rep, 2022
Cheng SK, Thompson I, Okeagu C, Nida Sen H.   +3 more
europepmc   +1 more source